rs185075003
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_005045.4(RELN):c.9478C>G(p.Leu3160Val) variant causes a missense change. The variant allele was found at a frequency of 0.000062 in 1,614,174 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L3160L) has been classified as Likely benign.
Frequency
Consequence
NM_005045.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RELN | NM_005045.4 | c.9478C>G | p.Leu3160Val | missense_variant | Exon 59 of 65 | ENST00000428762.6 | NP_005036.2 | |
| RELN | NM_173054.3 | c.9478C>G | p.Leu3160Val | missense_variant | Exon 59 of 64 | NP_774959.1 | ||
| SLC26A5-AS1 | NR_110141.1 | n.1366-13609G>C | intron_variant | Intron 2 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152172Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251260 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000622 AC: 91AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.0000591 AC XY: 43AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74468 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: RELN c.9478C>G (p.Leu3160Val) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 251260 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in RELN causing Epilepsy Familial Temporal Lobe 7 (5.6e-05 vs ND), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.9478C>G in individuals affected with Epilepsy Familial Temporal Lobe 7 and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted an assessment for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
Unlikely to be causative of RELN-related lateral temporal epilepsy (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 3160 of the RELN protein (p.Leu3160Val). This variant is present in population databases (rs185075003, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with RELN-related conditions. ClinVar contains an entry for this variant (Variation ID: 580355). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt RELN protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
RELN: PM2, PM3 -
RELN-related disorder Uncertain:1
The RELN c.9478C>G variant is predicted to result in the amino acid substitution p.Leu3160Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.010% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at